RecruitingNCT06377462
Multicenter, Interdisciplinary National VEXAS Registry With Accompanying Biomaterial Collection
Sponsor
Technische Universität Dresden
Enrollment
500 participants
Start Date
Mar 13, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
The aim is rapid collection of real-life data on the epidemiology, treatment and disease course in patients with VEXAS syndrome during routine clinical practice and collect biomaterials to evaluate genotype-phenotype associations, determine optimal treatment schedule, identify diagnostic features and biomarkers
Eligibility
Min Age: 18 Years
Inclusion Criteria3
- Patients with established or suspected (clinical and hematological criteria) VEXAS Syndrome
- Age ≥18 years
- Signed informed consent form
Exclusion Criteria1
- patients who are not in a position to understand the nature and scope of participation in this register
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(17)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06377462
Related Trials
A Study to Assess the Effectiveness and Safety of Pacritinib in Patients With VEXAS Syndrome (PAXIS)
NCT0678237339 locations
Pacritinib in Vacuoles, E1 Ubiqutin-activating Enzyme, X-linked, Autoinflammatory, Somatic (VEXAS) Syndrome
NCT065381811 location
AutoInflammatory Disease Alliance Registry (AIDA)
NCT05200715112 locations
Aplastic Anaemia and Other Bone Marrow Failure Syndromes Registry (AAR)
ACTRN1262300046169537 locations